Continuous‐duration maintenance therapy offers no overall survival gain in patients with newly diagnosed multiple myeloma
CA: A Cancer Journal for Clinicians · 2026-09 · 76 (5)
DOI: 10.3322/caac.70109 ↗Abstract
This news section offers CA readers timely information on scientific findings related to cancer diagnosis, patient care, treatment, and broader issues surrounding oncologic care. In this issue, a study finds that continuous‐duration maintenance therapy offers no overall survival gain in patients with newly diagnosed multiple myeloma. Also, patients receiving telehealth counseling plus free nicotine replacement therapy achieved nearly double the 6‐month smoking abstinence rate compared with those referred to the National Cancer Institute quit line.
EUVIMED